Official Journal Publication

Journal of PhytoPharmaceutical and Advanced Chemistry

Short Name: JPPAC• ISSN: 3139-9266• Peer-Reviewed Open Access

2026Volume 1 Issue 02, Pages 99-121• Published: July 27, 2026

Andrographis paniculata (Burm.f.) Nees: Bridging Traditional Medicine and Modern Pharmacological Applications

Contributing Authors
Naziya ParveenArvind Kumar PatelNeha SinghPushp Raj SinghDharmendra KumarLaliteshwar Pratap Singh
Digital Object Identifier (DOI):https://doi.org/10.66220/4mdpen52

Abstract

Andrographis paniculata (Burm. f.) Nees is a useful medicinal plant that's used in traditional medicine for treating inflammatory, infectious, metabolic and chronic diseases. This review provides a detailed investigation of its therapeutic versatility from a critical perspective based on traditional knowledge and authentic pharmacology and clinical findings. Hosted by the platform online, a systematic literature search was performed to find related articles from PubMed, Scopus, Web of Science, ScienceDirect and Google Scholar between the years 2000 and 2025. The search was done for papers that contained information related to Andrographis paniculata and the information was found in clinical studies, review articles, and original research articles. This review includes 58 publications chosen from the pool of relevant ones (predefined inclusion and exclusion criteria). Numerous bioactive constituents including diterpenoid lactones, flavonoids, and phenols have been found in Andrographis paniculata, with andrographolide being the major bioactive marker with diverse pharmacological activities and phytochemical constituents. These studies exhibit a lot of antioxidants, anti-inflammatory, antimicrobial, immunomodulatory, antidiabetic, cardioprotective, neuroprotective and anticancer effects. Modulation of the signalling pathway, such as NF-κB, Mitogen-Activated Protein Kinase (MAPK), Janus Kinase / Signal Transducer and Activator of Transcription (JAK/STAT), and oxidative stress, is the mechanism involved in such effects. Some clinical studies have demonstrated beneficial effects on some inflammatory markers and glycaemic parameters, as well as symptomatic benefit of some diseases, with an overall positive safety profile in limited clinical studies. However, there remain a number of restrictions for several reasons, firstly due to the variation of the phytochemical constituents of the plants, and lack of standardisation and secondly due to the absence of large-scale trials. Andrographis paniculata demonstrates considerable therapeutic potential across a wide range of disease conditions. Additional standardisation of formulations, advanced analytical techniques and extensive clinical studies are needed to determine its clinical effectiveness and to include it in evidence-based medicine.

Export Citation

Generate ready-to-use citations in standard scientific formats

Parveen, N., Patel, A. K., Singh, N., Singh, P. R., Kumar, D., & Singh, L. P. (2026). Andrographis paniculata (Burm.f.) Nees: Bridging Traditional Medicine and Modern Pharmacological Applications. Journal of PhytoPharmaceutical and Advanced Chemistry, Vol. 1(No. 02), pp. 99-121. https://doi.org/10.66220/4mdpen52

Cited References

60 References
  1. 01.

    1. Kim JK, Kim KH, Shin YC, Jang BH, Ko SG. Utilization of traditional medicine in primary health care in low- and middle-income countries: a systematic review. Health Policy Plan. 2020;35(8):1070–1083. doi: 10.1093/heapol/czaa022.

  2. 02.

    2. Tiwari SS, Honmane SM, Sarda RR, Gattani SG, Mahaparale PR, Hoque ME. Economic benefits of natural products in modern drug discovery in the twenty-first century. In Traditional Resources and Tools for Modern Drug Discovery: Ethnomedicine and Pharmacology 2024 Sep 28 (pp. 641-662). Singapore: Springer Nature Singapore. doi: 10.1007/978-981-97-4600-2_25.

  3. 03.

    3. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi: 10.1136/bmj.n71.

  4. 04.

    4. Newman DJ, Cragg GM. Natural Products as Sources of New Drugs over Nearly Four Decades. J Nat Prod. 2020;83(3):770–803. doi: 10.1021/acs.jnatprod.9b01285.

  5. 05.

    5. Venkata RB, Prasanth DS, Pasala PK, Panda SP, Tatipamula VB, Mulukuri S, Kota RK, Rudrapal M, Khan J, Aldosari S, Alshehri B. Utilizing Andrographis paniculata leaves and roots by effective usage of the bioactive andrographolide and its nanodelivery: investigation of antikindling and antioxidant activities through in silico and in vivo studies. Frontiers in Nutrition. 2023 May 31;10:1185236. doi: 10.3389/fnut.2023.1185236.

  6. 06.

    6. Duche-Pérez A, Gutiérrez Aguilar OA, Valero Quispe JL, Serruto Castillo A, Mamani Daza LJ. Systematic review of ethnomedicinal knowledge: Documentation, evaluation, and conservation of medicinal plants and their therapeutic applications. F1000Research. 2025 Dec 22;13:1324. doi: 10.12688/f1000research.157960.2.

  7. 07.

    7. Fatima, B., Mishra, U. and Singh, A., 2026. Medicinal and Nutritional Importance of Andrographis paniculata in Human Health. In Medicinal Plants and their Bioactive Compounds in Human Health: Volume 2 (pp. 531-547). Springer Nature Singapore. doi: 10.1007/978-981-95-3620-7_24.

  8. 08.

    8. Liu S, Liu J, Wang Y, Deng F, Deng Z. Oxidative stress: signaling pathways, biological functions, and disease. MedComm. 2025 Jul;6(7):e70268. doi: 10.1002/mco2.70268.

  9. 09.

    9. Paré G, Kitsiou S. Chapter 9 Methods for Literature Reviews. In: Lau F, Kuziemsky C, editors. Handbook of eHealth Evaluation: An Evidence-based Approach [Internet]. Victoria (BC): University of Victoria; 2017 Feb 27.

  10. 10.

    10. Erol A. Basics of Writing Review Articles. Noro Psikiyatr Ars. 2022 Jan 13;59(1):1-2. doi: 10.29399/npa.28093.

  11. 11.

    11. WHO. WHO Monographs on Selected Medicinal Plants. Geneva: World Health Organization; 2007.

  12. 12.

    12. Akowuah, G.A., Zhari, I., Norhayati, I., Sadikun, A., & Khamsah, S.M. (2006). Antioxidant activity and phenolic content of Andrographis paniculata extracts. Food Chemistry, 104(3), 1020–1026. doi: 10.55003/cast.2024.261033.

  13. 13.

    13. Jayakumar T., Hsieh C.Y., Lee J.J., Sheu J.R. (2013). Experimental and clinical pharmacology of Andrographis paniculata and its major bioactive phytoconstituent andrographolide. Evidence-Based Complementary and Alternative Medicine, 2013, 846740. doi: 10.1155/2013/846740.

  14. 14.

    14. Dai Y., Chen S.R., Chai L., Zhao J., Wang Y., Wang Y. (2019). Overview of pharmacological activities of andrographolide and its derivatives. Mini-Reviews in Medicinal Chemistry, 19(1), 17–29. doi: 10.1080/10408398.2018.1501657.

  15. 15.

    15. Mishra PK, Singh RK, Gupta A, Chaturvedi A, Pandey R, Tiwari SP, et al. Antibacterial activity of Andrographis paniculata (Burm. f.) Wall ex Nees leaves against clinical pathogens. Journal of Pharmacy Research. 2013;7(5):45962. doi: 10.1016/j.jopr.2013.05.009.

  16. 16.

    16. Singha, P.K., Roy, S., & Dey, S. (2003). Antimicrobial activity of Andrographis paniculata. Fitoterapia, 74(7–8), 692–694. doi: 10.1016/S0367-326X(03)00159-X.

  17. 17.

    17. Zhang X.F., Tan B.K.H. (2000). Antidiabetic property of ethanolic extract of Andrographis paniculata in streptozotocin-diabetic rats. Acta Pharmacologica Sinica, 21(12), 1157–1164.

  18. 18.

    18. Subramanian R., Asmawi M.Z., Sadikun A. (2008). In vitro α-glucosidase and α-amylase enzyme inhibitory effects of Andrographis paniculata and andrographolide. Journal of Ethnopharmacology, 117(3), 515–520. Doi: 10.18388/abp.2008_3087.

  19. 19.

    19. Ojha S.K., Bharti S., Joshi S., Kumari S., Arya D.S. (2012). Cardioprotective effects of Andrographis paniculata and andrographolide against myocardial injury. Indian Journal of Pharmacology, 44(2), 226–232.

  20. 20.

    20. Serrano F.G., Tapia-Rojas C., Carvajal F.J., Hancke J., Cerpa W., Inestrosa N.C. (2014). Andrographolide reduces cognitive impairment in animal models of Alzheimer's disease. Frontiers in Cellular Neuroscience, 8, 404. doi: 10.1186/1750-1326-9-61.

  21. 21.

    21. Jarukamjorn K, Nemoto N. Pharmacological Aspects of Andrographis paniculata on Health and Its Major Diterpenoid Constituent Andrographolide. Journal of Health Science. 2008;54:37081. doi: 10.1248/jhs.54.370.

  22. 22.

    22. Banerjee M, Chattopadhyay S, Choudhuri T, Bera R, Kumar S, Chakraborty B, et al. Cytotoxicity and cell cycle arrest induced by andrographolide lead to programmed cell death of MDA-MB-231 breast cancer cell line. Journal of Biomedical Science. 2016;23(1):40. doi: 10.1186/s12929-016-0257-0.

  23. 23.

    23. Kumar R.A., Sridevi K., Kumar, N.V., Nanduri, S., & Rajagopal, S. (2004). Anticancer and immunostimulatory compounds from Andrographis paniculata. Journal of Ethnopharmacology, 92(2–3), 291–295. doi: 10.1016/j.jep.2004.03.004.

  24. 24.

    24. Trivedi N.P., & Rawal U.M. (2001). Hepatoprotective and toxicological evaluation of Andrographis paniculata on liver damage models. Indian Journal of Pharmacology, 33(4), 288–293.

  25. 25.

    25. Handa, S. S., A. Sharma, and K. K. Chakraborti. Natural products and plants as liver protecting drugs. Fitoterapia (1986): 307-351.

  26. 26.

    26. Ding L., Wang L., Wang Z., Jiang H. (2014). Anti-obesity effects of andrographolide and Andrographis paniculata through regulation of adipogenesis and lipid metabolism. Phytotherapy Research, 28(6), 889–895. doi: 10.1124/jpet.114.217968.

  27. 27.

    27. Burgos RA, Alarcón P, Quiroga J, Manosalva C, Hancke J. Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism. Molecules. 2020;26(1). Doi: 10.3390/molecules26010005

  28. 28.

    28. Wasman SQ, Mahmood AA, Chua LS, Alshawsh MA, Hamdan S. Antioxidant and gastroprotective activities of Andrographis paniculata (Hempedu Bumi) in Sprague Dawley rats. Indian J Exp Biol. 2011;49(10):76772. Doi:

  29. 29.

    29. Thakur AK, Soni UK, Rai G, Chatterjee SS, Kumar V. Protective effects of Andrographis paniculata extract and pure andrographolide against chronic stress-triggered pathologies in rats. Cell Mol Neurobiol. 2014 Nov;34(8):1111-21. doi: 10.1007/s10571-014-0086-1.

  30. 30.

    30. Thisoda P., Rangkadilok N., Pholphana N., Worasuttayangkurn L., Ruchirawat M., Satayavivad J. (2006). Inhibitory effect of andrographolide on platelet aggregation and thrombus formation. Eur J Pharmacol. 2006 Dec 28;553(1-3):39-45. doi: 10.1016/j.ejphar.2006.09.052.

  31. 31.

    31. Amroyan E, Gabrielian E, Panossian A, Wikman G, Wagner H. Inhibitory effect of andrographolide from Andrographis paniculata on PAF-induced platelet aggregation. Phytomedicine. 1999 Mar;6(1):27-31. doi: 10.1016/S0944-7113(99)80031-2.

  32. 32.

    32. Panossian A, Davtyan T, Gukassyan N, Gukasova G, Mamikonyan G, Gabrielian E, Wikman G. Effect of andrographolide and Kan Jang--fixed combination of extract SHA-10 and extract SHE-3--on proliferation of human lymphocytes, production of cytokines and immune activation markers in the whole blood cells culture. Phytomedicine. 2002 Oct;9(7):598-605. doi: 10.1078/094471102321616409.

  33. 33.

    33. Thakur, A.K., Chatterjee, S.S., Kumar, V., & Bharati, S. (2013). Adaptogenic and anxiolytic-like effects of Andrographis paniculata and andrographolide in experimental models. Phytotherapy Research, 27(5), 699–705. doi: 10.1016/j.jtcme.2014.10.002.

  34. 34.

    34. Bosco F, Ruga S, Citraro R, Leo A, Guarnieri L, Maiuolo J, et al. The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases. Nutrients. 2023;15:3428. doi: 10.3390/nu15153428.

  35. 35.

    35. Wu T, Peng Y, Yan S, Li N, Chen Y, Lan T. Andrographolide Ameliorates Atherosclerosis by Suppressing Pro-Inflammation and ROS Generation-Mediated Foam Cell Formation. Inflammation. 2018 Oct;41(5):1681-1689. doi: 10.1007/s10753-018-0812-9.

  36. 36.

    36. Akbarsha MA, Manivannan B. Antifertility effect of Andrographis paniculata (Nees) in male albino rats. Indian Journal of Experimental Biology. 1990;28(5):421–426.

  37. 37.

    37. Allan JJ, Pore MP, Deepak M, et al. Reproductive and fertility effects of a standardized extract of Andrographis paniculata in male Wistar rats. International Journal of Toxicology. 2009;28(4):308–317. doi: 10.1177/1091581809339631.

  38. 38.

    38. Gupta S, Mishra KP, Ganju L. Broad-spectrum antiviral properties of andrographolide. Archives of Virology. 2017;162(3):611–623. doi: 10.1007/s00705-016-3166-3.

  39. 39.

    39. Yongyun C, Jingwei Z, Zhiqing L, Wenxiang C, Huiwu L. Andrographolide stimulates osteoblastogenesis and bone formation by inhibiting nuclear factor kappa-Β signaling both in vivo and in vitro. J Orthop Translat. 2019 Mar 2;19:47-57. doi: 10.1016/j.jot.2019.02.001.

  40. 40.

    40. Zhai ZJ, Li HW, Liu GW, Qu XH, Tian B, Yan W, Lin Z, Tang TT, Qin A, Dai KR. Andrographolide suppresses RANKL-induced osteoclastogenesis in vitro and prevents inflammatory bone loss in vivo. Br J Pharmacol. 2014 Feb;171(3):663-75. doi: 10.1111/bph.12463.

  41. 41.

    41. Zhu P-Y, Yin W-H, Wang M-R, Dang Y-Y, Ye X-Y. Andrographolide suppresses melanin synthesis through Akt/GSK3β/β-catenin signal pathway. Journal of Dermatological Science. 2015;79(1):7483. doi: 10.1016/j.jdermsci.2015.03.013.

  42. 42.

    42. Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y. Overview of pharmacological activities of Andrographis paniculata and its potential applications in dermatology and cosmetic science. Journal of Ethnopharmacology. 2019;236:243–256. doi: 10.1080/10408398.2018.1501657.

  43. 43.

    43. Chao WW, Lin BF. Isolation and identification of bioactive compounds in Andrographis paniculata and their protective effects against UV-induced oxidative damage and matrix metalloproteinase expression in skin cells. Journal of Ethnopharmacology. 2010;128(1):79–84. doi: 10.1186/1749-8546-5-17.

  44. 44.

    44. Bao Z, Guan S, Cheng C, Wu S, Wong SH, Kemeny DM, Leung BP, Wong WS. A novel antiinflammatory role for andrographolide in asthma via inhibition of the nuclear factor-kappaB pathway. Am J Respir Crit Care Med. 2009 Apr 15;179(8):657-65. doi: 10.1164/rccm.200809-1516OC.

  45. 45.

    45. Lu, Z. F., Min, J., Wu, X. C., Dong, B. H., Ye, J. M., Liu, X. B., … Gao, Z. J. (2020). Andrographolide inhibits secretagogue-induced pseudo-allergic reaction. Journal of Asian Natural Products Research, 22(11), 1065–1077. doi: 10.1080/10286020.2019.1681408.

  46. 46.

    46. Zhang Y, Zhang P, Yu P, Shang X, Fu Y, Lu Y, et al. Protective effects of andrographolide on lead-induced kidney injury through inhibiting inflammatory and oxidative responses in common carp. Aquaculture Reports. 2020;17:100395. doi: 10.1016/j.aqrep.2020.100395.

  47. 47.

    47. Singh P, Srivastava MM, Khemani LD. Renoprotective effects of Andrographis paniculata (Burm. f.) Nees in rats. Ups J Med Sci. 2009;114(3):136-9. doi: 10.1080/03009730903174321.

  48. 48.

    48. Mussard E, Cesaro A, Lespessailles E, Legrain B, Berteina-Raboin S, Toumi H. Andrographolide, a Natural Antioxidant: An Update. Antioxidants (Basel). 2019 Nov 20;8(12):571. doi: 10.3390/antiox8120571.

  49. 49.

    49. Coon JT, Ernst E. Andrographis paniculata in the treatment of upper respiratory tract infections: a systematic review of safety and efficacy. Planta Medica. 2004;70(4):293–298. doi: 10.1055/s-2004-818938.

  50. 50.

    50. Saxena RC, Singh R, Kumar P, et al. A randomized double-blind placebo-controlled clinical evaluation of Andrographis paniculata extract in upper respiratory tract infections. Phytomedicine. 2010;17(3–4):178–185. doi: 10.1016/j.phymed.2009.12.001.

  51. 51.

    51. Poolsup N, Suthisisang C, Prathanturarug S, Asawamekin A, Chanchareon U. Andrographis paniculata in symptomatic treatment of uncomplicated upper respiratory tract infection: systematic review of randomized controlled trials. Journal of Clinical Pharmacy and Therapeutics. 2004;29(1):37–45. doi: 10.1046/j.1365-2710.2003.00534.x.

  52. 52.

    52. Hu XY, Wu RH, Logue M, et al. Andrographis paniculata (Chuān Xīn Lián) for symptomatic relief of acute respiratory tract infections in adults and children: a systematic review and meta-analysis. PLoS One. 2017;12(8):e0181780. doi: 10.1371/journal.pone.0181780.

  53. 53.

    53. Sareer O, Ahmad S, Umar S. Andrographis paniculata: A critical appraisal of extraction, isolation and quantification of andrographolide and other active constituents. Nat Prod Res. 2014;28(23):2081–2101. doi: 10.1080/14786419.2014.924004.

  54. 54.

    54. Kunle OF, Egharevba HO, Ahmadu PO. Standardization of herbal medicines – A review. International Journal of Biodiversity and Conservation. 2012;4(3):101–112. doi: 10.5897/IJBC11.163.

  55. 55.

    55. Okhuarobo A, Falodun JE, Erharuyi O, Imieje V, Falodun A, Langer P. Harnessing the medicinal properties of Andrographis paniculata for diseases and beyond: a review of its phytochemistry and pharmacology. Asian Pac J Trop Dis. 2014 Jun;4(3):213–22. doi: 10.1016/S2222-1808(14)60509-0. doi: 10.1016/S2222-1808(14)60509-0.

  56. 56.

    56. Intharuksa A, Arunotayanun W, Yooin W, Sirisa-ard P. A Comprehensive Review of Andrographis paniculata (Burm. f.) Nees and Its Constituents as Potential Lead Compounds for COVID-19 Drug Discovery. Molecules. 2022; 27(14):4479. doi: 10.3390/molecules27144479.

  57. 57.

    57. Sahoo N, Manchikanti P, Dey S. Herbal drugs: Standards and regulation. Fitoterapia. 2010;81(6):462–471. doi: 10.1016/j.fitote.2010.02.001.

  58. 58.

    58. Dai Y, Chen SR, Chai L, Zhao J, Wang Y, Wang Y. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Critical Reviews in Food Science and Nutrition. 2019;59(sup1):S17–S29. doi: 10.1080/10408398.2018.1501657.

  59. 59.

    59. Songvut P, Boonyarattanasoonthorn T, Nuengchamnong N, Junsai T, Kongratanapasert T, Supannapan K, Khemawoot P. Enhancing oral bioavailability of andrographolide using solubilizing agents and bioenhancer: comparative pharmacokinetics of Andrographis paniculata formulations in beagle dogs. Pharm Biol. 2024 Dec;62(1):183-194. doi: 10.1080/13880209.2024.2311201.

  60. 60.

    60. Lim JCW, Chan TK, Ng DS, et al. Andrographolide and its analogues: A review of their pharmacological activities and medicinal chemistry. European Journal of Medicinal Chemistry. 2012;51:145–156. doi: 10.1111/j.1440-1681.2011.05633.x.

Suggested & Related Publications

Articles in related pharmaceutical, biomedical, and life sciences research on PharmSciGate

Explore Directory →
JPPAC2026 • pp. 18-29

Computational Study of Alkaloids Targeting O-GlcNAc Transferase as Antidiabetic Agents

Pardaev Jamshid; Umida Sadikova

O-GlcNAc Transferase (OGT) plays a pivotal role in glucose metabolism and insulin signaling, making it an attractive therapeutic target for the management of diabetes mellitus. In the present study, a comprehensive in silico approach was employed to investigate the inhibitory potential of selected alkaloids against human OGT, with an emphasis on their binding affinity and pharmacokinetic suitability. Molecular docking analysis was performed using AutoDock Vina to elucidate the interaction patterns between the selected compounds and the active site of OGT. The docking results revealed that berberine exhibited the strongest binding affinity (−7.8 kcal/mol), slightly surpassing that of the native ligand (−7.7 kcal/mol), and formed stable hydrogen bonding and hydrophobic interactions with key catalytic residues such as LYS898, ASN838, and PRO559. In contrast, castanospermine and swainsonine showed comparatively weaker binding affinities, attributed to limited interaction networks within the binding pocket. To further assess the drug development potential of the studied compounds, in silico ADMET analysis was carried out using SwissADME and ADMETlab 3.0. Berberine demonstrated favorable physicochemical properties, superior drug-likeness (highest QED score), and acceptable absorption and toxicity profiles compared to the native ligand and other alkaloids. Although potential cytochrome P450 interactions and moderate bioaccumulation were predicted for berberine, its overall pharmacokinetic profile was well balanced. Collectively, the integrated docking and ADMET results highlight berberine as a promising lead alkaloid targeting OGT, warranting further in vitro and in vivo validation for its potential development as an antidiabetic agent.

Full-Text Access

Access Type: Open Access
License:CC BY-NC 4.0
Language:en
Publishing Journal

Journal of PhytoPharmaceutical and Advanced Chemistry

An international, peer-reviewed journal integrating phytopharmaceutical sciences, natural products, and advanced pharmaceutical chemistry.

ISSN:3139-9266
DOI Prefix:10.5530/jppac
Visit Journal Portal
Indexed on PharmSciGate by SPBSRF

This peer-reviewed publication is indexed directly from the publisher repository adhering to Open Archives Initiative (OAI-PMH) metadata standards, Crossref DOI schema, and Google Scholar Highwire Press protocols.